Ophthalmic Suspension
Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with <em>Pseudomonas aeruginosa</em> infections
... and fibromyalgia. The patient was allergic to sulfa, penicillin, and tetracycline antibiotics. She was pseudophakic in both eyes with a history of Yag capsulotomy (OD). Concomitant medications included naproxen, ...
10
Clinical outcomes with besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis due to potentially consequential pathogens
... S. marcescens, Neisseria spp., or methicillin-resistant staphylococci with besifloxacin ophthalmic suspension 0.6% led to high rates of bacterial eradication of these pathogens of concern to eye care ...
11
Evaluation of dacryocystorhinostomy using optical coherence tomography and rebamipide ophthalmic suspension
... Purpose: To evaluate the surgical outcome of dacryocystorhinostomy (DCR) by measuring the tear meniscus, using optical coherence tomography and rebamipide ophthalmic suspension. Methods: Patients with ...
5
Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%)
... LE ophthalmic gel 0.5%, branded prednisolone acetate ophthalmic suspension 1%, and a generic prednisolone acetate ophthalmic suspension 1% (Pacific Pharma, Inc, Irvine, CA, USA) were ...
7
Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
... Presently, it was not elucidated whether or not the ef- ficacy of 2 % rebamipide ophthalmic suspension was dif- ferent between non-SS and SS. The presence of previous treatment showed the possibility of a ...
8
Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%
... This study evaluated the effects of bottle orientation during storage and the presence or absence of shaking on the uniformity of dispensed drops. Three bottles of each test article were stored in a defined orientation ...
6
<p>A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis</p>
... This was a randomized, double-masked, parallel-group, vehicle-controlled study that was planned across two medical centers, although all patients were enrolled at a single site in Brazil. Patients were randomized 1:1 to ...
10
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes
... besifloxacin ophthalmic suspension, or any of the ingredients in the study medications; had used topical ophthalmic anti-inflammatory agents within 48 hours before or during the study or other ...
9
Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal
... rebamipide ophthalmic suspension, in that it does not contain preservatives, which can cause destabilization of the tear film, disruption of the corneal epithelium, a decrease of the density of the goblet ...
8
NOVEL LONG OCULAR RETENTIVE FORMULATION DEVELOPMENT OF MICONAZOLE OPHTHALMIC SUSPENSION WITH HELP OF POLYMER PLATFORM SYSTEM
... miconazole ophthalmic suspension was developed using polymer system identified by principles of quality by design which will reduce the adverse effects associated with frequent ...acting ophthalmic ...
19
Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
... amethasone ophthalmic suspension) was instilled into the study eye four times daily for 2 weeks postsurgery. There were six postsurgical visits (days 1, 7, 14, 30, 60, and 90) in both studies. The only ...
9
Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study
... cin ophthalmic suspension ...besifloxacin ophthalmic suspension in the treatment of bacterial conjunctivitis that reported punc- tate keratitis at an incidence of ...
9
Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients
... In conclusion, in this retrospective chart review, the pro- phylactic use of besifloxacin ophthalmic suspension 0.6% in patients undergoing LASIK surgery was not associated with any ADRs. In addition, ...
8
The Effect of Prophylactic Administration of Ketorolac Ophthalmic Suspension on Prevention of Surgically Induced Miosis in Patients Undergoing Cataract Surgery
... The exclusion criteria were as follows: history of infectious disease, significant systematic disease, dry eye, connective tissue disease, pregnancy, narrow-angle or unstable glaucoma, history of iritis or trauma to ...
5
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile
... ciprofloxacin-resistant staphylococcal isolates far exceeded that of other ophthalmic fluoroquinolones. Results of sus- ceptibility retests indicated that besifloxacin was 4–128- fold more potent against ...
11
A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty
... LE suspension dosing, frequency, and duration; ocular inflammation (anterior chamber [AC] cells and flare); IOP (by Goldmann applanation tonometry); concomitant medications; visual acuity (VA; Snellen); and ...
11
Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients
... nac have been shown to reduce postoperative inflam- mation [7–10]. Some studies have shown that aqueous flare values in the early postoperative period are even lower in those treated with diclofenac sodium than in those ...
9
Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site
... 0.09% ophthalmic solution dosed QD and nepafenac 0.1% ophthalmic suspension dosed TID are well tolerated and resulted in positive clinical ...
8
Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery
... Background: The purpose of this study was to investigate the ocular bacterial flora in patients scheduled to undergo cataract surgery and compare the antibacterial effects of besifloxacin ophthalmic ...
10
Switching Study of Tafluprost/Timolol Fixed Combination Ophthalmic Solution, Following Unfixed Combination of Tafluprost Ophthalmic Solution 0 0015% and Timolol Ophthalmic Gel Forming Solution 0 5%
... drochloride ophthalmic solution, a brinzolamide ophthalmic suspension, a brimo- nidine tartrate ophthalmic solution, and a bunazosin hydrochloride ophthalmic solution (Table 1) were ...
15